One of the world’s most respected surgeons in the field of burns and trauma recovery will lead world-first clinical trials…
The world’s most lucrative healthcare market is quickly appreciating Aussie pharmaceuticals company Pharmaxis (ASX: PXS) whose cystic fibrosis (CF) treatment…